(AASLD) The Liver Meeting® 2026 - Oral Presentation
Nov 08, 2026 at 11:45 AM MST
Session: Clinical Trial Pipeline for MASH 2026
Abstract Title: Pemvidutide Treatment Results in Concurrent Reductions in Multiple Non-Invasive Tests for Hepatic Inflammation and Fibrosis: 48-Week Responder Analyses of the IMPACT Phase 2b Trial in Metabolic Dysfunction-Associated Steatohepatitis
Speaker: Dr. Naim Alkhouri
